SCHEMBL25753368

SCHEMBL25753368

Cc1cc(/C=N/[S+]([O-])C(C)(C)C)cc(C(F)(F)F)c1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24037015 1.00 NFE2L2 (0.33) NFE2L2RAPGEF4
SCHEMBL17243753 1.00 NFE2L2 (0.33) NFE2L2RAPGEF4
SCHEMBL17243756 0.91 FBP1 (0.31)
SCHEMBL15212873 0.91 FBP1 (0.31)
SCHEMBL17233148 0.91 FBP1 (0.31)
SCHEMBL17233211 0.91 FBP1 (0.31)
SCHEMBL17233146 0.91 FBP1 (0.31)
SCHEMBL4934471 0.85 GPR3 (0.32)
SCHEMBL4934477 0.85 GPR3 (0.32)
SCHEMBL24037017 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 NFE2L2 2985/4885RAPGEF4 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.